Protalix BioTherapeutics, Inc.
PLX
$1.93
$0.021.05%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 30.27M | 29.37M | 33.40M | 34.74M | 34.83M |
| Total Receivables | 9.47M | 14.43M | 9.44M | 4.68M | 3.40M |
| Inventory | 25.73M | 21.26M | 21.13M | 19.51M | 21.24M |
| Prepaid Expenses | 394.00K | -- | -- | -- | 500.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 803.00K | 1.45M | 1.51M | 1.59M | 110.00K |
| Total Current Assets | 66.67M | 66.50M | 65.49M | 60.51M | 60.08M |
|
|
|||||
| Total Current Assets | 66.67M | 66.50M | 65.49M | 60.51M | 60.08M |
| Net Property, Plant & Equipment | 12.58M | 12.53M | 9.74M | 9.95M | 10.02M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.09M | 3.23M | 3.26M | 3.43M | 3.32M |
| Total Assets | 82.35M | 82.26M | 78.49M | 73.89M | 73.42M |
|
|
|||||
| Total Accounts Payable | 5.26M | 5.38M | 6.69M | 4.12M | 4.53M |
| Total Accrued Expenses | 14.53M | 11.64M | 11.81M | 14.87M | 13.80M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.38M | 1.40M | 1.47M | 1.43M | 1.50M |
| Total Finance Division Other Current Liabilities | 5.35M | 3.54M | 4.12M | 3.90M | 5.79M |
| Total Other Current Liabilities | 5.35M | 3.54M | 4.12M | 3.90M | 5.79M |
| Total Current Liabilities | 26.52M | 21.95M | 24.09M | 24.32M | 25.62M |
|
|
|||||
| Total Current Liabilities | 26.52M | 21.95M | 24.09M | 24.32M | 25.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.94M | 6.78M | 3.88M | 3.81M | 4.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 661.00K | 631.00K | 615.00K | 551.00K | 559.00K |
| Total Liabilities | 34.12M | 29.36M | 28.58M | 28.68M | 30.21M |
|
|
|||||
| Common Stock & APIC | 433.23M | 432.40M | 431.75M | 427.22M | 421.60M |
| Retained Earnings | -385.00M | -379.49M | -381.85M | -382.01M | -378.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 48.23M | 52.91M | 49.90M | 45.21M | 43.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.23M | 52.91M | 49.90M | 45.21M | 43.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.23M | 52.91M | 49.90M | 45.21M | 43.21M |
|
|
|||||